MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $376,446 | +227.7% | 296,414 | -28.6% | 0.01% | +125.0% |
Q2 2023 | $114,875 | -94.0% | 415,000 | -10.3% | 0.00% | -93.1% |
Q1 2023 | $1,901,693 | -99.9% | 462,699 | +22.9% | 0.06% | +20.8% |
Q3 2022 | $2,545,000,000 | +12.2% | 376,496 | -23.3% | 0.05% | +45.5% |
Q2 2022 | $2,269,000,000 | – | 491,048 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |